November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Perioperative XELOX for gastric cancer with extensive lymph node metastases
Nov 12, 2024, 13:21

Perioperative XELOX for gastric cancer with extensive lymph node metastases

Erman Akkus, Medical oncology fellow at the Ankara University, shared an article by Yutaka Kimura on X:

“Perioperative XELOX for gastric cancer with extensive lymph node metastases.

  • Paraaortic LN metastases and/or bulky LN.
  • 3XELOX-surgery-5XELOX.\
  • phase II, 30 patients.
  • RR: 66.7%.
  • ChT completion rate: 96.7%.
  • Curative resection rate: 93.3%.”

Perioperative XELOX for gastric cancer with extensive lymph node metastases

Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701).

Authors: Yutaka Kimura, et al.

Perioperative XELOX for gastric cancer with extensive lymph node metastases

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.